Predictive tests in cancer. Tuesday 9 April 1974.
D000367:Age Factors; D001943:Breast Neoplasms / Q000188:drug therapy / Q000201:enzymology; D002465:Cell Movement; D004796:Clinical Enzyme Tests; D003110:Colonic Neoplasms / Q000201:enzymology; D003561:Cytarabine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000627:therapeutic use; D004338:Drug Combinations; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007700:Kinetics; D007938:Leukemia / Q000188:drug therapy; D015122:Mercaptopurine / Q000627:therapeutic use; D008722:Methods; D008727:Methotrexate / Q000627:therapeutic use; D008956:Models, Chemical; D009369:Neoplasms / Q000175:diagnosis*; D011379:Prognosis; D012509:Sarcoma / Q000188:drug therapy; D013739:Testosterone / Q000378:metabolism; D013866:Thioguanine / Q000627:therapeutic use
D004338:Drug Combinations; D003561:Cytarabine; D013739:Testosterone; D004317:Doxorubicin; D015122:Mercaptopurine; D013866:Thioguanine; D005472:Fluorouracil; D008727:Methotrexate